Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

28 min ago | TheStreet.com

Why Pfizer (PFE) Stock Is Down Today

The acquisition grants Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and encephalitis vaccine, FSME-IMMUN, along with a part of Baxter's Austrian facility that produces the drugs.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, TheStreet

1 hr ago | Pharmaceutical Processing

Baxter to Sell Commercial Vaccines Business to Pfizer

Baxter International has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a total cash consideration of $635 million, subject to certain adjustments.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Baxter International, E.Factor, Medical Equipment, Influenza, Health, Lyme Disease

3 hrs ago | Philly.com

Merck CEO seeks drug add-ons, not large tax-inversion deals

Merck & Co., the second-biggest U.S. drugmaker, is staying in the United States and sticking to a bolt-on acquisition strategy, shunning the route taken by its biggest rival, Pfizer Inc. Merck, maker of the diabetes pill Januvia, is not interested in large-scale purchases that are "very time-consuming and distracting to what we're here to do, which ... (more)

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, North Wales, PA, Lansdale, PA

7 hrs ago | Barron's

Morning Movers: BP, UPS, Drugmakers

Russia's bad behavior is having an impact on integrated oil giant BP , which warned that increasing Western sanctions on Russia could hurt given its nearly 20% stake in state oil company Rosneft.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Aetna, Insurance, Financial Markets

Tue Jul 29, 2014

Seeking Alpha

Pfizer's (PFE) CEO Ian Read on Q2 2014 Results - Earnings Call Transcript

Good day, everyone and welcome to Pfizer's Second Quarter 2014 Earnings Conference Call.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

The Washington Post

Pfizer CEO Is Impatient for Tax Reform as He Hunts for Deals

Failing to buy AstraZeneca Plc with the drug industry's largest-ever deal hasn't stopped Pfizer Inc.'s Ian Read from looking far and wide for acquisitions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, US News, US Politics, US Senate, Ron Wyden, Democrat, Carl Levin, Business News

Insider Monkey

Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan

Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc. has to go for some kind of acquisition to strengthen its pipeline and because of that, I think, Pfizer Inc. in May, when the latter turned down its $118 billion bid offer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Consulting, Frost and Sullivan, Merck

Business Journal

Accelerator Corp. raises $51M, will expand to New York

Acclerator Corp., a Seattle a life-science investment firm that focuses on biotech businesses, said it's raised $51.1 million in capital funding, and will expand to New York City.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer

TheStreet.com

U.S. Stocks Higher as Merck, Pfizer Top Expectations

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Financial Markets, Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Mozilla

Business Journal

Polaris names former Pfizer exec as area's first female VC partner

Helping reverse a nationwide trend of fewer female venture capitalists in recent years, Polaris Partners has named the only female partner currently at any of the area's top VC firms.

Comment?

Related Topix: Venture Capital, Emerging Technology, Biotech, Medicine, Healthcare Industry

Newsday

Earnings: UPS profit slides; Pfizer tops estimates; Merck doubles; Aetna inches higher

United Parcel Service driver Marty Thompson starts his truck up after making a delivery in Cumming, Ga.

Comment?

Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Pfizer, Transportation, Trucking, United Parcel Service, Air Courier, Expedited Group, Cumming, GA, Forsyth County, GA

PE Hub

Polaris hires Pfizer general counsel Schulman as venture partner

Polaris Partners , which is in the market for a $400 million seventh fund, has brought on board a noted healthcare general counsel.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Waltham, MA

Vallejo Times-Herald

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Collinsville, IL

WTHR-TV Indianapolis

Pfizer's 2Q profit sinks 79 pct but tops forecasts

Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Natural Disasters, Wildfire, Fire

Customer Interaction Solutions

Pfizer Reports Second-Quarter 2014 Results

Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment ; the Global Vaccines, Oncology and Consumer Healthcare segment ; ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Centers for Disease Control and Prevention

The Globe and Mail

Pfizer beats forecasts as cancer medicine sales grow

The Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York, on May 4, 2014.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Associated Press

Benzinga

Stocks To Watch For July 29, 2014

Wall Street expects Pfizer to report its Q2 earnings at $0.57 per share on revenue of $12.46 billion.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Trucking, United Parcel Service, Air Courier, Transportation, Travelers Express Company, Financial Services, Fresh Del Monte Produce, Agriculture

Mon Jul 28, 2014

Wall Street Journal

Wanted: Startups in Biotech

The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Healthcare Industry, Eli Lilly, Opinion

Seeking Alpha

The Product Development Story Of Provectus Biopharmaceuticals

When Provectus Biopharmaceuticals Inc. announced at the end of May that the FDA had denied it Breakthrough Therapy Designation it caused a sharp drop in the stock price.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry

Seeking Alpha

Whisper Number Impact: How Will Pfizer's Stock Move After Earnings?

Pfizer has a 59% positive surprise history . The overall average post earnings price move is 'positive' when the company reports earnings.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••